Placebo for fezolinetant film-coated tablets 45 mg, fezolinetant
2693-CL-1303
Phase 3 small_molecule active
Quick answer
Placebo for fezolinetant film-coated tablets 45 mg, fezolinetant for Moderate to Severe Vasomotor Symptoms (VMS) is a Phase 3 program (small_molecule) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma GmbH
- Indication
- Moderate to Severe Vasomotor Symptoms (VMS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active